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Molecular-cytogenetic variant in chronic myeloid leukemia
Variantes citogenético-moleculares na leucemia mielóide crônica
Maria de Lourdes L. F. Chauffaille
Chronic myeloid leukemia (CML) was the first
neoplastic disease to be linked to a genetic abnormality
and is the best studied molecular model of leukemia.
The increased and cumulative knowledge of this
disease has recently received special attention due
mainly to the new therapeutic option, a signal
transducer inhibitor, the imatinib mesylate.
CML diagnosis is based on the presence of the
translocation between chromosomes 9 and 22, known
as the Philadelphia chromosome (Ph), which provides
the physical link between BCR and ABL genes.
At diagnosis, the karyotype is still the first test
to be made to detect the Ph chromosome, though,
besides the t(9;22), it may reveal other concomitant
translocations, which may or may not indicate clonal
evolution and consequent accelerated/blastic phase.
The so-called "Philadelphia variant" (Phvar), which
involves different chromosomes besides 9 and 22,
may also be detected by this method. Phvar has
been found in 5% of CML cases.1
At diagnosis, fluorescent in situ hybridization
(FISH) and reverse-transcriptase polymerase chain
reaction (RT-PCR) are extremely useful for cases in
which the karyotype does not show abnormalities
(masked Ph),2 or the marrow fibrosis eludes adequate
sample collection for chromosomal analysis. As
molecular methods do not allow the observation of
concomitant cytogenetic abnormalities, they have been
performed in addition to karyotyping.
FISH is a practical technique for demonstrating
the location of specific nucleic acid sequences
(probe) in individual metaphase or interphase cells.
These DNA probes contain a label (fluorescence)
that allows their detection after hybridization to the
target of interest.3
Using FISH probes, very interesting data about
CML have been demonstrated. The first generation
of FISH probes (single fusion) was manufactured
in order to show a signal for ABL gene (for example,
a red dot – digoxigenin) and a signal in a different
color for BCR gene (for example, a green dot –
FITC). In a normal cell four separated colored
signals are seen, two red and two green, while in
an abnormal cell with Ph, three colored dots, an
isolated red, an isolated green and a fusion signal,
red/green or yellow dot, corresponding to the BCR/
ABL rearrangement, are observed.
These single fusion probes can be used to
rapidly diagnose, in interphase or metaphase, cells
with t(9;22) if the cells comprise the majority of the
sample.4 However, as there may be, due to random
chance, a mere geographic juxtaposition of red and
green signals in the cell imitating a false fusion, even
normal samples may have a background false-
positive. So, each laboratory has to establish its nor-
mal range through the analysis of control samples
from healthy individuals. This value varies from
3% to 15% according to technical skills in each lab.5
The second set of FISH probes was
manufactured in order to bypass this inconvenient
false-positivity. It was designed to exhibit a small
extra signal (ES) (red, for instance) on the
derivative chromosome 9 by making the ABL probe
larger so that a residual signal is left on the 9q.
Thus, the normal pattern would still be two isolated
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red dots and two isolated green dots similar to
what is seen through the single probe. But in the
abnormal cell there would be a green signal, two
red signals, one corresponding to the normal allele,
one smaller (corresponding to the derivative 9q)
and a yellow signal corresponding to the BCR/ABL
fusion. In this way, only the cells with the extra
signal would be counted as bearing the Ph
translocation. The level of detection is increased
and the normal range is more accurate.4,6
Another set of FISH probes, known as dual
fusion set (DF) was designed to span the break-
points, leaving behind a residual signal on the
derivative 9q proximally and extending the signal
on the derivative 22q below the break. In other
words, the probes hybridizing to ABL and to BCR
are larger and this creates a second fusion signal
on the derivative 9q. So, with this probe set, nor-
mal cells would still be detected as two isolated
green and two isolated red signals, while the
abnormal cell would show two fusion signals, one
smaller, and a red and a green signal. The advantage
of this combination is that the resulting abnormal
pattern would occur very rarely as false positive or
artifact. The sensitivity of the dual fusion set is very
good depending on how many cells are counted.7
Due to the increasing use of these probes, a
number of cases that present a variety of abnormal
situations, like the loss of the extra signal or of the
dual fusion in the presence of Philadelphia, are
being detected. These situations are also being
called variants, but more specifically, “molecular-
cytogenetic variants”.8 Cases with deletion of BCR
or ABL genes near the regions where those
enlarged probes hybridize show that additional
phenomena to the translocation occur and are
perhaps related to a worse prognosis.9-11
The RT-PCR is also a powerful method for the
detection of specific sequences and allows the
detection of different transcripts giving rise to the
210 kDa BCR/ABL protein, most frequent in CML
(M-bcr), the 190kDa BCR/ABL protein, frequent in
Ph-positive acute lymphoblastic leukemia (ALL) (m-
bcr), or the 230kDa BCR/ABL protein, very rarely
found (µ-bcr).
Some studies have shown no correlation
between CML chronicity and breakpoint sites while
others have shown that m-bcr breakpoints develop
blast crisis with monocytosis.12
The case presented in this issue by Carvalho
et al, is a clear example of a usual clinical CML
presentation that hides diverse molecular aspects,
proving that this disease has a multitude of
intriguing underlying biological events. Cases like
this can only be detected by performing conventional
chromosomal G-banding, FISH and RT-PCR
altogether.
CML deserves more investigational studies
directed to elucidate these aspects and still has a
lot to teach us.
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